Gain Therapeutics Inc

NASDAQ:GANX   3:59:51 PM EDT
6.52
-0.23 (-3.41%)
Other Pre-Announcement

Gain Therapeutics Inc Reports Third Quarter 2021 Financial Results And Business Update

Published: 11/12/2021 12:42 GMT
Gain Therapeutics Inc (GANX) - Gain Therapeutics, Inc. Reports Third Quarter 2021 Financial Results and Business Update.
Q3 GAAP Loss per Share $0.39.
$40.98 Million in Cash As of September 30, 2021, Provides Runway Into Second Half of 2023.